Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Green Light For First OTC Naloxone In US After FDA Raises Caution Flag During Advisory Panel

Mar 30 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Serves Notice: Approval Of OTC Naloxone Could Close Prescription Sales

Nov 16 2022

Rx Naloxone Marketer's OTC Switch Proposal For Nasal Spray Gets Priority Review From FDA

Dec 06 2022

Emergent’s OTC Naloxone Single-Panel Instruction List Prompts Doubletake From US FDA Officials

Feb 16 2023

Urgency For Approval Of OTC Naloxone In US Weighed Against Using Untested Package Labeling

Feb 16 2023

Related Companies

Emergent BioSolutions, Inc.

Additional Topics

International United States US States FDA Approvals Prescription To OTC Switch Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer Drug Approval Standards Drug Safety Ingredients Manufacturing OTC Drugs Policy Politics Regulation Retail Advisory Committees Research & Development

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window